These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 1707922)
1. Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. Riddell SR; Rabin M; Geballe AP; Britt WJ; Greenberg PD J Immunol; 1991 Apr; 146(8):2795-804. PubMed ID: 1707922 [TBL] [Abstract][Full Text] [Related]
2. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. McLaughlin-Taylor E; Pande H; Forman SJ; Tanamachi B; Li CR; Zaia JA; Greenberg PD; Riddell SR J Med Virol; 1994 May; 43(1):103-10. PubMed ID: 8083644 [TBL] [Abstract][Full Text] [Related]
3. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens. Tabi Z; Moutaftsi M; Borysiewicz LK J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411 [TBL] [Abstract][Full Text] [Related]
4. Alloreactive cytotoxic CD4+ responses elicited by cytomegalovirus-infected endothelial cells: role of MHC class I antigens. Weinberg A; Zhang L; Hayward AR Viral Immunol; 2000; 13(1):37-47. PubMed ID: 10733167 [TBL] [Abstract][Full Text] [Related]
5. The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL. van Binnendijk RS; Poelen MC; Kuijpers KC; Osterhaus AD; Uytdehaag FG J Immunol; 1990 Mar; 144(6):2394-9. PubMed ID: 2107259 [TBL] [Abstract][Full Text] [Related]
6. Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled. Tigges MA; Leng S; Johnson DC; Burke RL J Immunol; 1996 May; 156(10):3901-10. PubMed ID: 8621929 [TBL] [Abstract][Full Text] [Related]
7. Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection. Manley TJ; Luy L; Jones T; Boeckh M; Mutimer H; Riddell SR Blood; 2004 Aug; 104(4):1075-82. PubMed ID: 15039282 [TBL] [Abstract][Full Text] [Related]
8. HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells. Lindsley MD; Torpey DJ; Rinaldo CR J Immunol; 1986 Apr; 136(8):3045-51. PubMed ID: 2420881 [TBL] [Abstract][Full Text] [Related]
9. Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. Hengel H; Esslinger C; Pool J; Goulmy E; Koszinowski UH J Gen Virol; 1995 Dec; 76 ( Pt 12)():2987-97. PubMed ID: 8847504 [TBL] [Abstract][Full Text] [Related]
10. [Immune reaction to human cytomegalovirus]. Ito M Nihon Rinsho; 1998 Jan; 56(1):62-8. PubMed ID: 9465666 [TBL] [Abstract][Full Text] [Related]
11. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens. Browning MJ; Huang AS; Reiss CS J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651 [TBL] [Abstract][Full Text] [Related]
12. The Q7 alpha 3 domain alters T cell recognition of class I antigens. Aldrich CJ; Lowen LC; Mann D; Nishimura M; Hood L; Stroynowski I; Forman J J Immunol; 1991 May; 146(9):3082-90. PubMed ID: 1849941 [TBL] [Abstract][Full Text] [Related]
13. NK recognition of cytomegalovirus-infected endothelial cells depends on viral replication and MHC class I expression. Weinberg A; Zhang L; Tuder RM Viral Immunol; 1996; 9(2):131-40. PubMed ID: 8822629 [TBL] [Abstract][Full Text] [Related]
14. The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen. Milligan GN; Morrison LA; Gorka J; Braciale VL; Braciale TJ J Immunol; 1990 Nov; 145(10):3188-93. PubMed ID: 1700000 [TBL] [Abstract][Full Text] [Related]
15. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants. Lucas KG; Sun Q; Burton RL; Tilden A; Vaughan WP; Carabasi M; Salzman D; Ship A Hum Gene Ther; 2000 Jul; 11(10):1453-63. PubMed ID: 10910142 [TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes. Gehrz RC; Rutzick SR Clin Exp Immunol; 1985 Jul; 61(1):80-9. PubMed ID: 2994924 [TBL] [Abstract][Full Text] [Related]
18. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. Koelle DM; Chen HB; Gavin MA; Wald A; Kwok WW; Corey L J Immunol; 2001 Mar; 166(6):4049-58. PubMed ID: 11238653 [TBL] [Abstract][Full Text] [Related]
19. CD8 T cell-evasive functions of human cytomegalovirus display pervasive MHC allele specificity, complementarity, and cooperativity. Ameres S; Besold K; Plachter B; Moosmann A J Immunol; 2014 Jun; 192(12):5894-905. PubMed ID: 24808364 [TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus matrix protein PP150 is efficiently presented as one of target antigens for cytotoxic T lymphocyte recognition. Li C; Yang X; Tu W; Riddell SR Chin Med J (Engl); 1997 May; 110(5):397-400. PubMed ID: 9594311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]